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SUMMARY A role for the copper transporter, ATP7B, in secretion of copper from the hu-
man breast into milk has previously not been reported, although it is known that the murine
ortholog of ATP7B facilitates copper secretion in the mouse mammary gland. We show here
that ATP7B is expressed in luminal epithelial cells in both the resting and lactating human
breast, where it has a perinuclear localization in resting epithelial cells and a diffuse location
in lactating tissue. ATP7B protein was present in a different subset of vesicles from those
containing milk proteins and did not overlap with Menkes ATPase, ATP-7A, except in the
perinuclear region of cells. In the cultured human mammary line, PMC42-LA, treatment with
lactational hormones induced a redistribution of ATP7B from a perinuclear region to a region
adjacent, but not coincident with, the apical plasma membrane. Trafficking of ATP7B was
copper dependent, suggesting that the hormone-induced redistribution of ATP7A was
mediated through an increase in intracellular copper. Radioactive copper (64Cu) studies using
polarized PMC42-LA cells that overexpressed mAtp7B protein showed that this transporter
facilitates copper efflux from the apical surface of the cells. In summary, our results are
consistent with an important function of ATP7B in the secretion of copper from the human
mammary gland. (J Histochem Cytochem 56:389–399, 2008)
KEY WORDS
ATP7B
copper
mammary gland
secretion
lactational hormones
AN ADEQUATE supply of copper is essential during nor-
mal growth and development, and in mammals, this is
delivered to the neonate in milk. During lactation in
rats, there is a 20-fold increase in transport of plasma
copper to the mammary gland (Donley et al. 2002).
Copper concentrations in milk are high after birth
(0.4–0.6 mg/liter in humans) but decrease during late
lactation both in humans (0.2–0.3 mg/liter) (Perrone
et al. 1993; Lo¨nnerdal 1996; Wooten et al. 1996; Friel
et al. 1999) and rodents (Linder et al. 1998). The supply
of copper to milk may be regulated by hormonal con-
trol of copper fluxes into and out of the mammary gland
during lactation.
The mechanisms by which copper enters the mam-
mary gland and is secreted into milk are not established.
Copper transporters including ATP7B have been im-
plicated in the movement of copper into milk. ATP7B is
a P-type ATPase with six transmembrane domains and
six metal-binding sites responsible for the translocation
of copper across cell membranes. ATP7B is predomi-
nantly located in the liver, but recently has been iden-
tified in breast and placental tissue along with another
copper efflux protein, ATP7A (Michalczyk et al. 2000;
Hardman et al. 2007). The clearest indication that
ATP7B is involved in copper secretion is provided by
the phenotype of the toxic milk (tx) mouse mutant. This
autosomal recessive condition is caused by a mutation
in Atp7b, the murine ortholog of ATP7B (Theophilos
et al. 1996). Homozygous mice accumulate massive
amounts of hepatic copper because of the failure of the
biliary excretion of copper, mediated by Atp7b. A simi-
lar condition occurs in humans with Wilson disease.
Paradoxically, the mutant tx dams produce copper-
deficient milk that may lead to the death of the pups
(Rauch 1983). In Atp7b knockout mice, the absence
of ATP7b also results in the accumulation of copper
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within the mammary gland to a level twice that of the
wild type (Buiakova et al. 1999). This is consistent with
the concept that, whereas the copper uptake pathway
into the mammary gland is functional, the secretion of
copper into milk is impaired.
The tx mouse expresses normal levels of the mutant
Atp7b, but this protein has been shown to be non-
functional with regard to Cu transport (Voskoboinik
et al. 2001). Moreover, Atp7b fails to relocalize from
the trans-Golgi network to vesicles in response to cop-
per, a phenomenon displayed by normal Atp7b (La
Fontaine et al. 2001). Similarly, we have also shown
in the tx homozygous mouse that Atp7b does not
relocalize in the lactating mammary gland, thus con-
tributing to the failure of normal copper delivery to
milk (Michalczyk et al. 2000).
Although Atp7b is clearly involved in delivery of
copper to milk in mice, a function for ATP7B in copper
secretion into milk by human mammary epithelial cells
has not been established. In patients with Wilson dis-
ease, copper concentrations in the milk of lactating
mothers have not been tested. To determine the involve-
ment of ATP7B in secretion of copper into milk, we
used a cell culture model of the human breast, PMC42-
LA (Ackland et al. 2001). PMC42-LA cells are unique
in their capacity to express milk proteins when stim-
ulated with lactogenic hormones in the presence of ex-
tracellular matrix. In these cells, expression of b-casein,
the major human-specific milk protein, and milk-
specific gene expression were induced through hor-
mone and matrix interactions similar to those operating
in vivo (Ackland et al. 2001).
In this study, we show for the first time that ATP7B
is present in human breast epithelial cells and that its
localization, as in mice, is altered during lactation.
Using PMC42-LA cells, we show that lactational hor-
mones induce relocalization of ATP7B, in a copper-
dependent manner, and that overexpression of ATP7B
increases apical secretion of copper, consistent with a
key role of ATP7B in copper secretion into milk.
Materials and Methods
Human Tissue and Cell Line
Two samples of tissue from disease-free resting and
lactating human breasts were obtained from breast bi-
opsies performed for diagnosis of breast disease. Tissue
was immediately frozen at –80C until use.
The breast adenocarcinoma cell line PMC42-LA, a
variant of the PMC42 line, originally derived from a
pleural effusion (Whitehead et al. 1983), was cultured
in RPMI 1640 culture media (Trace Bioscience; Mel-
bourne, Australia) supplemented with 10% FBS (CSL;
Melbourne, Australia). The cells were passaged when
confluent using 0.05% trypsin-versene solution in PBS
(Sigma-Aldrich; Sydney, Australia). To induce cellular
differentiation, PMC42-LA cells were grown on porous
Transwell filters (Costar; EK Medical, Melbourne,
Australia) coated with a thin layer of 1:5 diluted EHS
matrix (from Engelbreth Holm-Swarm mouse sarcoma;
Sigma-Aldrich) in RPMI 1640 media. Differentiated
PMC42-LA cells were treated with lactogenic hor-
mones to obtain cellular model of lactating epithelia
as we previously described (Ackland et al. 2001,2003).
Briefly, cells were grown to confluency, and they were
treated with 2.7 ng/ml b-estradiol (Sigma-Aldrich) and
157 ng/ml progesterone (Sigma-Aldrich) for 3 days,
followed by 3-day treatment of 1 mg/ml dexamethasone
(Sigma-Aldrich), 0.6 mg/ml insulin (Sigma-Aldrich), and
200 ng/ml prolactin (Jomar Diagnostic; Melbourne,
Australia). The cells grown on the porous Transwell
filters were processed for immunofluorescence or har-
vested for protein analysis.
Antibodies
A polyclonal antibody against the human ATP7B pro-
tein was prepared after the immunization of a rabbit
(Institute of Medical and Veterinary Science; Adelaide,
South Australia) with a peptide that spanned copper-
binding sites 4 and 5 (MPEQERQITAREGASRKI)
conjugated to Diphtheria toxoid (Chiron Technologies;
Melbourne, Australia). ATP7B antiserum was precip-
itated with sodium sulfate. A polyclonal rabbit anti-
mouse Atp7b antibody, sheep anti-human ATP7A (R17)
antibody, and sheep anti-human ATP7B (NC36) anti-
body were raised as previously described (Michalczyk
et al. 2000; Cater et al. 2004; Ke et al. 2006). A poly-
clonal rabbit antibody against total human milk pro-
teins was a gift from Charles H. Streuli (Lee et al. 1985;
Streuli et al. 1991). MUC1 (BC2 murine monoclonal
anti-human mucin) antiserum was kindly supplied by
Ian McKenzie (Xing et al. 1989). Monoclonal antibody
to b-casein was purchased from Harlan Sera-Lab (Mel-
bourne, Australia).
IHC
Tissue blocks (1 cm3) were immersed in OCT compound
(Tissue Tek; Melbourne, Australia), frozen in liquid
nitrogen for 3 min, and sectioned (CM 1800 cryostat;
Leica, North Ryde, Australia) between 220C and
217C. Sections of 8–10 mm thickness were collected on
gelatin (5%)-coated slides. Samples from resting and
lactating breasts were processed concurrently. The
sections were dried and fixed in 4% paraformaldehyde,
rinsed twice for 10 min in PBS, permeabilized with 5%
Triton X-100 in PBS for 5 min, and blocked with 3%
BSA in PBS for 90 min. Primary antibody to human
ATP7B diluted 1:500 in 1% BSA in PBS was applied to
tissues for 2 hr at room temperature. After three PBS
washes, second antibody AlexaFluor 488 donkey anti-
rabbit IgG (Molecular Probes; Eugene, OR) 1:2000
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dilution in 1% BSA in PBS was applied for 2 hr.
Sections were washed in PBS and mounted in Fluoro-
guard antifade reagent (Bio-Rad Laboratories; Hercu-
les, CA). Confocal images were collected using a Leica
confocal microscope system TCS SP2 (Leica).
Immunocytochemistry
PMC42-LA cells grown on 1-cm2 glass coverslips or
on EHS matrix–coated (diluted 1:5 in media) porous
Transwell cell culture inserts were fixed in 4% parafor-
maldehyde for 10 min, permeabilized with 0.1% Triton
X-100 in PBS for 10 min, and blocked with 3% BSA in
PBS for 90 min. Primary antibodies diluted in 1% BSA
in PBS [1 in 100 for hATP7B, 1 in 50 for mAtp7b, 1 in
4000 for hATP7B(NC36), 1 in 500 for hATP7A(R17),
1 in 50 for b-casein antibody, 1 in 100 for total milk
proteins, and 1 in 200 for MUC1] were applied to cells
overnight at 4C. After PBS washes, a secondary antibody
AlexaFluor 488 donkey anti-rabbit IgG, AlexaFluor
488 goat anti-mouse IgG, or AlexaFluor 488 donkey
anti-sheep IgG (Molecular Probes) 1 in 2000 dilution in
1% BSA in PBS was applied for 2 hr at room tempera-
ture. Additional AlexaFluor 568 donkey anti-sheep or
AlexaFluor 568 donkey anti-mouse secondary anti-
bodies (Molecular Probes) were added to cells at 1 in
2000 dilution for 2 hr, when double label was needed.
After washing off excess secondary antibodies, ethid-
ium bromide (10 mg/ml; diluted 1 in 10,000) was added
to some cells for 3 min to enable visualization of the
nuclei. Cells were washed in PBS and mounted in
Fluoroguard antifade reagent (Bio-Rad; Sydney, Aus-
tralia). Confocal images were collected using a Leica
confocal microscope system TCS SP2 (Leica). When
applicable, a colocalization analysis plug-in for ImageJ
1.383 (I. Collins and W. Rasband; National Institutes
of Health, Bethesda, MD) was used to quantify colocal-
ization of fluorescence from different channels. Thresh-
old Manders colocalization coefficients (Manders et al.
1993) were applied for ATP7B (tM1; channel 1) and
b-casein or total milk proteins (tM2; channel 2) using
automatic threshold determination according to Costes
et al. (2004). Zero/zero pixels were excluded. The val-
ues for percentage of pixels colocalized from different
channels are presented.
Western Blot Analysis
Breast tissue (100 mg) was disrupted in liquid nitrogen,
homogenized in a Dounce homogenizer, sonicated (15
pulses, 40% power output, 30% duty cycles; Microson
XL2000Ultrasonic Cell Disruptor,Misonix, Farmingdale,
NY) on ice in 1 ml of EDTA-free inhibitor cocktail
(Roche Diagnostics; Melbourne, Australia) containing
20 mg/ml SDS and 5 mM b-mercaptoethanol, and cen-
trifuged for 5 min at 18,000 3 g. PMC42-LA cells
grown in 80-cm2 plastic flasks were washed twice with
PBS, trypsinized, and collected as a cell pellet by centri-
fugation at 3000 3 g for 5 min. The cell pellet was re-
suspended in 300–500 ml EDTA-free inhibitor cocktail
containing 20 mg/ml SDS and 5 mM b-mercaptoethanol.
Cells were lysed by repeated passages through a 21-gauge
needle followed by sonication as for breast tissue. The
total protein content of tissue and cells extracts was
measured using the DC Protein Assay Kit (Bio-Rad
Laboratories) calibrated against BSA standards. The
cell extracts (40 mg protein) and breast tissue super-
natants (100 mg protein) were fractionated by SDS-
PAGE and transferred to nitrocellulose membranes
(Pall Gelman & Whatman; Dassal, Germany). After
1 hr blocking in 1% (w/v) casein in TBS at room tem-
perature, membranes were exposed overnight to anti-
human ATP7B polyclonal antibodies or anti-mouse
Atp7b polyclonal antibodies, both diluted 1/500 in
1% (w/v) casein in TBS. Membranes were rinsed in
blocking buffer, and human ATP7B and mouse Atp7b
were detected using 1/2000 dilution of horseradish
peroxidase–conjugated goat anti-rabbit secondary anti-
body (Silenus;Melbourne, Australia) in 1% (w/v) casein
in TBS for 2 hr at room temperature. After removal of
excess secondary antibody, membranes were rinsed
twice in TBS with 0.1% Tween 20 (Sigma-Aldrich).
Proteins were detected by enhanced chemiluminescence
(POD Chemiluminescence Blotting Substrate; Roche
Diagnostics) and a LAS-3000 FujiFilm Lumino-Image
Analyzer (Fuji Photo Film; Tokyo, Japan). To monitor
protein loading, membranes were stripped in Re-Blot
solution (Chemicon International; Temecula, CA) and
reprobed with monoclonal b-actin primary antibody
(Sigma-Aldrich) diluted 1/5000. Densitometry to quan-
tify results was performed using Fuji Film Multi Gauge
V2.3 computer software, and ratios for protein levelswere
calculated relative to b-actin controls.
Plasmid Construction and Cell Transfections
The full-length mouse Atp7b cDNA construct was pre-
pared as described in La Fontaine et al. (2001) and
designated pCMB98. The empty pcDNA3.1 vector
(Invitrogen; Melbourne, Australia) was used for cell
transfections as a vector-control. For stable transfec-
tions, PMC42-LA cells were incubated in the presence
of the construct pCMB98 or vector pcDNA3.1 and
Lipofectamine 2000 transfection reagent (Life Tech-
nologies; Melbourne, Australia) following the manu-
facturer’s instructions. The clone selection was carried
out in 300 mg/ml of G418 (Life Technologies) for
3 months. Screening of G418-resistant transfectants for
expression of mouse Atp7b protein was carried out by
indirect immunofluorescence.
Accumulation of Radioactive Copper Assay
PMC42-LA cells transfected with pCMB98 plasmid
(mouse Atp7b) or pcDNA3.1 vector (vector-control) were
grown to confluency on EHS matrix–coated (diluted
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1:10 in media), porous Transwell cell culture inserts.
The monolayers integrity was determined by measuring
transepithelial resistance using an ohmmeter. Radioac-
tive copper (64Cu) was purchased from ARI, Australian
Nuclear Science and Technology Organization (Lucas
Heights, Australia). The average radioactive concen-
tration of 64Cu was 2.61 GBq/ml of copper in the form
of CuCl2 diluted in 0.1 M HCl. Growth media were
supplemented with 1.0–2.0 ml 64Cu/ml and non-
radioactive copper to final concentrations of 0.15 and
0.5 mM. Cells were incubated in this media for 6 hr.
After 6 hr, the membranes were rinsed with cold HBSS
and solubilized with 0.2 M KOH. The cell-associated
radioactivity was measured with a Minaxi Auto Gamma
counter (Canberra-Packard; Toronto, ON, Canada).
Copper accumulation was normalized to the protein
concentration of the cell lysate (quantified using a Bio-
Rad Protein Assay Kit; Bio-Rad Laboratories).
64Cu Transport Assay
PMC42-LA cells transfected with pCMB98 plasmid
(mouse Atp7b) or pcDNA3.1 vector (vector-control) were
grown to confluency on EHSmatrix–coated (diluted 1:10
in media), porous Transwell cell culture inserts. One to
2 ml 64Cu/ml (2.61 GBq/ml radioactive concentration
of 64Cu) was added to the media containing non-
radioactive copper to final concentrations of 0.15 and
0.5 mM. This medium was added to the basolateral
chamber. Media aliquots were taken from the apical
chamber after 0.5, 1, 3, and 6 hr and counted using a
Minaxi Auto Gamma counter.
Statistical Analysis
All experiments were repeated in triplicate, and values
are expressed as means 6 SD. Student’s t-tests were
used to determine statistical differences between treat-
ments using the statistical software SPSS 12; p,0.05
was considered significant.
Results
ATP7B Protein Is Present in Both Resting and
Lactating Breasts
To determine whether ATP7B was expressed in human
breast tissue and to study the effect of lactation, protein
extracts from biopsies of human breasts were analyzed
by Western blots. A polyclonal antibody to human
ATP7B detected a single band of size 165 kDa con-
sistent with the expected size of the ATP7B protein
(Figure 1A). Comparison of the relative amounts of
ATP7B protein to housekeeping protein b-actin (Fig-
ure 1A) by densitometry (5.9 6 0.4 to 6.2 6 0.5 rela-
tive density units) indicated there was no difference in
the amounts of ATP7B in resting and lactating tissue.
Immunofluorescence of human breast tissue sections
indicated thatATP7Bwas present inmost luminal epithe-
lial cells of both resting and lactating breast tissue. In the
resting breast, ATP7B had a predominantly perinuclear
location, with a small proportion of labeling in the cyto-
plasm (Figure 1B1), whereas in lactating tissue, ATP7B
had a more diffuse granular cytoplasmic localization in
addition to a perinuclear component (Figure 1B2).
Lactational Hormones Alter the Intracellular
Distribution of ATP7B Protein in the Breast Cell Model
To study whether the redistribution of ATP7B in the
lactating breast was because of the influence of lacta-
tional hormones, we used PMC42-LA human breast
epithelial cells (Ackland et al. 2001). Our initial experi-
ments were carried on non-polarized cells grown on a
glass substrate using standard cell culture medium:
RPMI with 10% FBS. In these cells, ATP7B was located
exclusively in the perinuclear regions (Figure 2A1).
Atomic absorption spectrophotometric analysis of
cell culture medium (RPMI with 10% FBS) indicated
that the copper level was 0.3 mM, which is consid-
erably lower than total human plasma copper levels
(11–22 mM), even considering that only z25–35%
of plasma copper may be available to cells (Linder
1991,2002). Cells growing in RPMI with 10% FBS
may therefore have quite low cytoplasmic copper levels.
ATP7B would be predicted to remain in the trans-Golgi
network (La Fontaine et al. 2001). When we grew cells
in increasing concentrations of copper from basal
(0.3 mM) to 100 mM, the intracellular distribution of
ATP7B changed from perinuclear to a granular cyto-
plasmic distribution following increases in copper con-
centration (Figures 2A1–2A3).
To provide a more physiologically relevant model of
the lactating human gland, we grew PMC42-LA cells on
EHS matrix on a porous membrane, which induced
epithelial cell differentiation and polarization (Ackland
et al. 2001,2003). The cells were treated with estrogen
and progesterone followed by dexamethasone, insulin,
and prolactin to mimic the physiological hormonal
changes within the breast during lactation. In the pres-
ence of copper chelator bathocuproine disulfonate
(BCS), a perinuclear localization of ATP7B was found
in both hormone-treated and non-treated cells (Fig-
ures 2B1 and 2B2). In standard cell culture medium
(0.3 mM copper), ATP7B was located in the perinuclear
regions of the non-treated PMC42-LA cells (Figure 2B3).
Hormone treatment induced a more diffuse cytoplasmic
staining of ATP7B (Figure 2B4). When the hormone
treatment was repeated in the presence of 5 mM cop-
per, ATP7B changed from a mainly perinuclear lo-
calization (Figure 2B5) to a predominantly punctate
cytoplasmic label in hormone-treated cells (Figure 2B6).
Treatment of cells with 100 mM copper resulted in
a general punctate cytoplasmic distribution of ATP7B
in both non-treated and hormone-treated cells (Fig-
ures 2B7 and 2B8).
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In hormone-treated PMC42-LA cells, ATP7B pro-
tein was located near the apical membrane.
Double-labeling immunofluorescence was used to
further study the localization of ATP7B in differenti-
ated PMC42-LA cells. PMC42-LA cells were grown on
EHS matrix on a porous membrane in the presence of 5
mM copper with and without hormones. Cells were
labeled with anti-ATP7B antibody (Figures 3A1 and
3A4) and anti-MUC1 antibody to mucin glycoprotein.
MUC1 had an apical localization (Figures 3A2 and
3A5), consistent with its presence as a resident of the
apical membrane in breast epithelial cells (Patton et al.
1995). ATP7B labeling did not overlap with the MUC1
in either the non–hormone-treated PMC42-LA cells
(Figure 3A3) or in the hormone-treated cells (Figure 3A6),
indicating that most of the ATP7B protein was not
present in the vicinity of the apical membrane. The XZ
sections further support the absence of ATP7B from
the apical membrane (Figure 3A3¶); however, they
showed that hormones caused redistribution of ATP7B
toward the apical region of the PMC42-LA cytoplasm
(Figure 3A6’).
In cultured PMC42-LA cells, ATP7B protein did not
colocalize with milk proteins and only partially over-
lapped with ATP7A.
Colocalization studies using an antibody to b-casein
and an antibody to total milk proteins in humans showed
that, in differentiated hormone-treated PMC42-LA
cells, ATP7B did not entirely overlap with either b-
casein or milk proteins, suggesting that some ATP7B was
not in the same secretory vesicles (Figures 3B1–3B3).
Threshold Manders coefficients were 12% and 34% for
Figure 1 (A) Representative Western
blot analysis of human breast tissue.
Tissue extracts (100 mg) were separated
on 7.5% SDS-PAGE, and ATP7B protein
(165 kDa) was detected using a poly-
clonal antibody for humanATP7B. Lane
1, resting human breast tissue extract;
Lane 2, lactating human breast tissue
extract. b-actin protein (42 kDa) was
used as a loading control in same tissue
extracts. (B) IHC localization of human
ATP7B in section of an alveolus from
human breast tissues. (B1) ATP7B was
localized to the perinuclear region (pn)
of epithelial cells in resting breast tis-
sue. (B2) Granular, diffuse cytoplasmic
label (cp) of ATP7B with some peri-
nuclear fraction (pn) was detected in
lactating breast tissue. Bar 5 12 mm.
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Figure 2 (A) Immunocytochemical
localization of human ATP7B (green)
in non-differentiated PMC42-LA cells
grown on glass in (A1) basal copper
concentration (0.3 mM), (A2) 5 mM
copper, and (A3) 100 mM copper for
3 days. (B) Immunocytochemical local-
ization of human ATP7B (green) in
differentiated PMC42-LA grown on
EHS matrix–coated Transwell filters.
Cells were cultured in (B1,B2) 50 mM
bathocuproine disulfonate, (B3,B4)
basal copper, (B5,B6) 5 mM copper,
and (B7,B8) 100 mM copper for 3 days.
Cells (B2,B4,B6,B8) were subjected to
lactogenic hormone treatment as de-
scribed in the Materials and Methods
section. Nuclei of the cells were stained
with ethidium bromide (red), and all
images were collected using Leica con-
focal system.Bars:A510mm;B512mm.
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ATP7B and b-casein, respectively, indicating that only
12% of the ATP7B label overlapped with b-casein and
34% of b-casein overlapped with ATP7B. When an
antibody raised to total human milk proteins was used,
only partial colocalization with ATP7B protein was
detected (Figures 3B4–3B6) with threshold Manders
coefficients of 57% for ATP7B and 52% for total milk
protein. This suggested that approximately one half the
Figure 3 (A) Double-label immuno-
fluorescence of ATP7B (green) and
mucin glycoprotein MUC1 (red) in dif-
ferentiated PMC42-LA cells. Cells were
grown in the presence of 5 mM cop-
per with (A4,A5,A6,A6¶) and without
(A1,A2,A3,A3¶) hormones. XZ sec-
tions of staining overlay are shown
on the right side. (B) Localization of
hATP7B (green) (B1,B4) in differenti-
ated, hormone-treated PMC42-LA cells
in comparison to b-casein (red) (B2) and
total human milk proteins (red) (B5).
Overlays of the images are shown
(B3,B6). (C) Double-label immuno-
fluorescence of ATP7B (green) and
hATP7A (red) in differentiated PMC42-
LA cells. Cells were grown in the pres-
ence of 5 mM copper with (C4–C6)
and without (C1–C3) hormones. Bar 5
10 mm.
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ATP7B may co-reside in vesicles that are associated
with milk proteins, whereas the remainder is not asso-
ciated with the milk secretory pathway.
Double-label immunofluorescence was carried out
to determine the extent of intracellular colocalization
between ATP7B and ATP7A. Overlap of these ATPases
occurred in the perinuclear region, seen in non–
hormone-treated cells (Figures 3C1–3C3). In hormone-
treated cells, ATP7B had a granular label that extended
further from the nucleus compared with ATP7A (Fig-
ures 3C4–3C6).
ATP7B Mediates Transport of Copper From the
Cell Through the Apical Membrane in Cultured
PMC42-LA Cells
To establish whether ATP7B functioned as a copper
transporter in breast epithelial cells, an ATP7B con-
struct pCMB98 (La Fontaine et al. 2001) was intro-
duced into PMC42-LA cells, and 64Cu transport studies
were carried out. Expression of mouse Atp7b protein
in PMC42-LA cells was confirmed by the presence of a
band of 165 kDa corresponding to the expected size of
the mouse protein (Figure 4A), using an antibody raised
to mouse Atp7b. The band was detected only in trans-
fected cells and was absent from vector-only transfected
cells, because this antibody is specific to mouse Atp7b
and does not cross-react with human ATP7B (Fig-
ure 4A). A strong perinuclear Atp7b stain was observed
in transfected cells after immunofluorescence using the
mouse-specific antibody (Figure 4B1). This pattern was
similar to that observed for the endogenous protein
(Figure 2A1). After treatment of transfected cells with
200 mM copper for 2 hr, Atp7b had a granular cyto-
plasmic distribution in addition to perinuclear locali-
zation (Figure 4B2). The effect of expression of Atp7b
on copper transport in mammary epithelial cells was
determined using transfected and non-transfected
PMC42-LA cells grown on EHS-coated porous filters.
The integrity of the monolayer was indicated by a trans-
epithelial resistance of 300 V/cm2, within the normal
range of 150–600 V/cm2 (Artursson et al. 1996). 64Cu
was added to the basal compartment of the PMC42-LA
Figure 4 (A) Representative Western
blot analysis of PMC42-LA cells trans-
fected with pCMB98 plasmid (mouse
Atp7b) or pcDNA3.1 vector (vector-
control). Sixty mg of cell extracts was
separated on 7.5% SDS-PAGE, and
Atp7b protein (165 kDa) was detected
using a polyclonal antibody for mouse
Atp7b. Lane 1, pcDNA3.1 vector trans-
fected cell extract; Lane 2, pCMB98
plasmid transfected cell extract. b-
actin protein (42 kDa) was used as a
loading control in same cell extracts.
(B) Immunocytochemical localization
of mouse Atp7b in PMC42-LA cells
transfected with pCMB98 plasmid.
(B1) Atp7b was localized to the peri-
nuclear region of PMC42-LA cells when
grown in basal copper levels. (B2)
Granular, diffuse cytoplasmic label of
Atp7b with some perinuclear fraction
was detected in PMC42-LA cultured in
200 mM copper. Bar 5 10 mm.
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cells, and the accumulation of copper in the cells together
with copper transport from basal into the apical
compartment was determined in the presence of 0.15
and 0.5 mM total copper concentration. In the presence
of 0.15 mM copper, there was no difference in 64Cu
accumulation in control and in cells expressing mouse
Atp7b. In the presence of 0.5 mM copper, cells express-
ing the Atp7b accumulated less copper than control cells
in 6 hr (p,0.001; Figure 5A). In addition, in cells
expressing the Atp7b, significantly more 64Cu was trans-
ported across the cell monolayer to the apical compart-
ment than in control cells in the presence of copper
concentrations of 0.5 mM (p,0.001; Figure 5B).
Discussion
A function for ATP7B in the transport of copper from
human mammary epithelial cells into milk has not
previously been reported. In this study, we analyzed the
expression and cellular localization of ATP7B in the
resting and lactating human mammary gland. ATP7B
protein had a perinuclear localization in cells from the
resting breast, whereas in the lactating breast, the pro-
tein was redistributed throughout the cytoplasm of the
luminal epithelial cells. This observation is consistent
with our previous studies of the mammary gland in
non-lactating and lactating mice (Michalczyk et al.
2000) and data from lactating rats showing punctate
staining of Atp7b in a region of the cell adjacent to the
luminal surface of the epithelial cells (Kelleher and
Lo¨nnerdal 2003,2006). The data suggest that the in-
tracellular relocalization of ATP7B could be associated
with physiological secretion of copper into milk during
lactation. This conclusion is supported by our previous
data from the tx mouse showing that the defect in
delivery of copper into milk is accompanied by a failure
of the ATP7B protein to relocalize (Michalczyk et al.
2000). It is not known if there is a defect in copper
secretion into milk in mothers with Wilson disease,
caused by mutations in the ATP7B gene, because there
are no reports in the literature of copper levels in the
milk of patients.
Analysis of ATP7B in the human mammary gland
indicated no differences between the amount of protein
in the resting and lactating breast. This suggests that the
capacity of ATP7B to facilitate copper transport into
milk does not need increased amounts of the protein.
This finding is consistent with a previous study in mouse
mammary tissue where we also found no differences in
ATP7B protein levels between the resting and lactating
glands. (Michalczyk et al. 2000) but different from
another study where a reduction in Atp7b protein of
z25% was seen after the decline in the milk copper
levels during lactation in rats (Kelleher and Lo¨nnerdal
2006). It is possible that these differences in results may
reflect species differences.
Although similar levels of ATP7B protein were seen
in lactating and resting breast tissue, this pattern is in
contrast to the ATP7A protein previously found in
human and mouse mammary tissue. ATP7A was more
highly expressed in lactating tissue compared with
resting tissue in the human gland (Ackland et al. 1999),
as well as in the mouse gland (Michalczyk et al. 2000).
This suggests a fundamental difference in the physio-
logical regulation and possibly the function of these two
Figure 5 (A) The effect of expression of Atp7b on copper accumu-
lation in PMC42-LA cells. Cells transfected with pCMB98 plasmid or
pcDNA3.1 vector were grown to confluency on EHS matrix–coated,
porous Transwell cell culture inserts. Growth media were supple-
mented with 64Cu and non-radioactive copper to final concentra-
tions of 0.15 and 0.5 mM, and cells were cultured in it for 6 hr. Copper
accumulation was normalized to the protein concentration of the
cell lysate. Bars represent mean 64Cu accumulation 6 SD from three
experiments. Asterisks denote a significant difference (p,0.001). (B)
The effect of expression of Atp7b on copper transport in PMC42-LA
cells. PMC42 cells, transfected with pCMB98 plasmid or pcDNA3.1
vector, were treated with media containing 64Cu and non-radioac-
tive copper to final concentrations of 0.15 and 0.5 mM. This medium
was added to the basolateral chamber. Media aliquots were taken
from the apical chamber after 0.5, 1, 3, and 6 hr and were counted
using a Minaxi Auto Gamma counter. Copper accumulation was
normalized to the protein concentration of the cell lysate. Bars rep-
resent mean 64Cu levels 6 SD from three experiments.
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ATPases in lactation, despite the fact that ATP7B can
partially substitute for ATP7A in the Menkes-deficient
mottled fibroblast cell line (Payne et al. 1998). The fact
that some copper is transported into milk in the absence
of ATP7B (Michalczyk et al. 2000) suggests the pres-
ence of additional copper transporters or mechanisms
of secretion in the mammary gland. ATP7A has been
considered for this role, but there is contradictory evi-
dence relating to localization of this protein in the
breast tissue. In the mammary gland of lactating rats,
Atp7a was found to be associated with the apical and
basolateral membranes of epithelial cells, suggesting
that Atp7a localization is compatible with its role in
lactogenic hormone stimulated copper secretion (Kelleher
and Lo¨nnerdal 2006). Conversely, our current study in
mice (unpublished data) and a previous study on trans-
fected MDCK cells showed basolateral membrane lo-
calization of ATP7A (Greenough et al. 2004), which
may not be consistent with efflux of copper from the
apical surface.
We used the PMC42-LA humanmammary epithelial
cell line to further study the intracellular location of
ATP7B and to determine the effects of hormones. We
first grew PMC42-LA in RPMI with 10% FBS on a
normal glass substrate. Cells grown on glass showed a
very tight perinuclear staining of ATP7B, different from
the perinuclear and cytoplasmic label found in the
resting breast. We speculated that the tight perinuclear
label could be caused by lower than physiological levels
of copper present in standard RPMI culture medium
with 10% FBS (0.3 mM) and that the lack of copper
in the culture medium could explain why ATP7B was
somewhat refractory to hormone-induced relocaliza-
tion relative to cells grown in 5 and 100 mM copper. In
support of this hypothesis, we found that, in hormone-
treated PMC42-LA cells grown in 5 mM copper, the
localization of ATP7B changed from perinuclear to
granular cytoplasmic. In response to increased extra-
cellular copper levels (100 mM), only a punctated cyto-
plasmic ATP7B pattern was found, and there was no
difference between hormone-treated and non-treated
cells. Additionally, in the presence of a copper chelator
(BCS), ATP7B did not relocalize from the perinuclear
region in response to hormones. These data suggest that
hormones may act to change the localization of ATP7B
through an increase in intracellular copper levels, to
facilitate the efflux of copper from mammary epithelial
cells into milk.
The PMC42-LA cell line can be manipulated to
represent both resting and lactating secretory breast
epithelia. The resting model was produced by grow-
ing PMC42-LA cells on EHS matrix above a permeable
basal membrane. Under these conditions, cells have
tight junctions and are polarized but do not synthesize
milk proteins. The lactating model was induced by hor-
mone treatment of PMC42-LA cells on the EHS matrix,
which stimulated b-casein synthesis (Ackland et al.
2001). We used confocal microscopy to determine
whether ATP7B was present in vesicles containing milk
proteins that are destined for secretion during lactation.
After hormone treatment, most of the ATP7B did not
colocalize with the major human milk protein, b-casein;
however, z50% overlapped with total milk protein,
suggesting some ATP7B may be in the milk secretory
pathway. ATP7B migrated toward the apical region of
the cell but did not overlap with the apical marker,
MUC1, indicating that it was not at the plasma mem-
brane itself. This is similar to observations made in
primary rat liver hepatocytes and HepG2 cells, where
ATP7B trafficked from the trans-Golgi to cytoplasmic
vesicular compartment in response to copper adminis-
tration (Schaefer et al. 1999; Cater et al. 2006). Cell
fractionation of HepG2 cells showed that ATP7B was
present in an intracellular compartment pathway and
not associated with the plasma membrane after copper
treatment (Hung et al. 1997). Similarly, also in HepG2
cells, a plasma membrane lawn assay showed that
ATP7B was not localized to plasma membrane (Yang
et al. 1997). In contrast to these reports, there is also
evidence that ATP7B is associated with the plasma
membrane in copper-treated HepG2 cells (Roelofsen
et al. 2000; Guo et al. 2005).
To prove that ATP7B mediated cellular copper
fluxes, 64Cu studies were carried out on polarized
PMC42-LA cells grown on EHS on a porous filter. In
cells expressing mouse Atp7b in addition to the endoge-
nous human ATP7B, in the presence of 0.5 mM copper,
there was a significant decrease in cellular copper ac-
cumulation and an increase in copper in the apical
compartment relative to control cells. In the presence of
0.15 mM copper, the overexpressing cells did not ac-
cumulate more copper compared with the controls.
This observation supports the concept that low levels of
extracellular copper are insufficient to induce the
copper trafficking of ATP7B that is needed for copper
efflux from cells. The 64Cu data also confirm that
ATP7B is involved in copper efflux through the apical
surface of the cells, possibly with assistance of some
other, yet unidentified, protein.
In summary, ATP7B is expressed in the resting and
lactating human breast, where it is located in the lumi-
nal epithelial cells. ATP7B has a perinuclear localiza-
tion in resting epithelial cells and a diffuse location
in lactating tissue. Experiments using the PMC42-LA
human mammary model showed that hormones induce
a redistribution of ATP7B from a perinuclear region to
a compartment adjacent but not at the apical plasma
membrane. Physiological concentrations of extracellu-
lar copper are needed for lactational hormones to in-
duce trafficking of ATP7B, suggesting that hormones
act indirectly through increased intracellular copper to
mediate copper secretion from mammary epithelial cells
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during lactation. 64Cu studies with cells overexpressing
ATP7B showed that it facilitates copper efflux from
mammary epithelial cells from the apical surface.
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